MedTrace Logo

Scandinavian Diverticulitis Trial SCANDIV-II

NCT04254224 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2020-02-05

No results posted yet for this study

Summary

This study focuses on the treatment for complicated diverticulitis classified as Hinchey I-IV.

The aim of this prospective observational study is to evaluate type of treatment and the success rate of treatment in acute complicated diverticulitis (ACD) at participating hospitals in Sweden and Norway. Furthermore, the effects on quality of life for this patient group will be evaluated.

Conditions

  • Diverticulitis Colon

Interventions

PROCEDURE

colon resection, stoma

oral or intravenous antibiotics treatment with or without percutanous or transrectal or transvaginal drainage

Sponsors & Collaborators

  • Centrallasarettet Västerås

    collaborator OTHER

  • Mora Hospital, Landstinget Dalarna

    collaborator UNKNOWN

  • Uppsala University Hospital

    collaborator OTHER

  • University Hospital, Linkoeping

    collaborator OTHER

  • Danderyd Hospital

    collaborator OTHER

  • Sahlgrenska University Hospital

    collaborator OTHER

  • Stockholm South General Hospital

    collaborator OTHER

  • Uppsala University

    lead OTHER

Principal Investigators

  • Abbas Chabok, MD, PhD · Uppsala University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-10
Primary Completion
2022-04-10
Completion
2024-09-10

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04254224 on ClinicalTrials.gov